Top 5 Drug Classes Advertising in Professional Health Journals (Dollars) through April 2013

by Client Services

Total print advertising dollars in professional health journals surpassed $185 million through April, according to Kantar Media. Cancer Therapy Products was the top product class with more than $13 million spent and also took the top spot last month. The top product classes by dollars are as follows:

Top 5 Print Ad Drug Classes (Dollars): Jan. – April 2013

#1 Cancer Therapy Products – $14 MM (+13%)

#2 Anticoagulants Oral – $10 MM (+10%)

#3 Irritant Stimulant Laxatives– $4 MM (N/A)

#4 Steroids, Inhaled Bronch – $4 MM (N/A)

#5 Diabetes Insulin – $4 MM (-34%)

The percentage changes compare January – April 2013 to that same time period in 2012. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.